VANCOUVER, BC & SAN FRANCISCO– AbCellera (Nasdaq: ABCL) and Versant Ventures today announced a multi-year collaboration to discover therapeutic antibodies for multiple targets selected by Versant’s portfolio of biologics-focused biotechs. Versant and AbCellera… Read More
New site in Burnaby, B.C., will be a Center of Excellence for Cytiva’s Aseptic Filling business. Robotic aseptic filling workcells reduce risk and increase flexibility in pharmaceutical manufacturing. Global life… Read More
– Companies aim to support development of up to 15 new genomic medicine products– Replicate’s commercial licensing of lipid nanoparticle technology from Precision NanoSystems at foundation of deal SAN DIEGO… Read More
KIRKLAND – Today, Pfizer Canada and BioNTech filed a New Drug Submission (NDS) with Health Canada for an Omicron-adapted bivalent COVID-19 vaccine candidate, based on the BA.1 sub-lineage, to be… Read More
Phase 2 clinical trial recently expanded to include adolescents following independent review of early safety data First adolescent patient with EB enrolled into clinical trial and completed treatment International patent… Read More
